CXCL16 and rheumatoid arthritis: Thus far, these studies suggest that monocyte infiltration and/or type 1 cytokine production in the RA joint may enhance local production of soluble CXCL16, which may exacerbate local inflammation via recruitment of CXCR6+ T cells.